139 related articles for article (PubMed ID: 31833405)
1. miRNA deregulation in childhood acute lymphoblastic leukemia: a systematic review.
Gutierrez-Camino A; Garcia-Obregon S; Lopez-Lopez E; Astigarraga I; Garcia-Orad A
Epigenomics; 2020 Jan; 12(1):69-80. PubMed ID: 31833405
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
3. lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review.
Illarregi U; Telleria J; Bilbao-Aldaiturriaga N; Lopez-Lopez E; Ballesteros J; Martin-Guerrero I; Gutierrez-Camino A
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35419612
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Valiollahi E; Ribera JM; Genescà E; Behravan J
Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246
[TBL] [Abstract][Full Text] [Related]
5. MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.
Akbari Moqadam F; Lange-Turenhout EA; Ariës IM; Pieters R; den Boer ML
Leuk Res; 2013 Oct; 37(10):1315-21. PubMed ID: 23915977
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
7. Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia.
Umerez M; Garcia-Obregon S; Martin-Guerrero I; Astigarraga I; Gutierrez-Camino A; Garcia-Orad A
Pharmacogenomics; 2018 Mar; 19(4):361-373. PubMed ID: 29469670
[TBL] [Abstract][Full Text] [Related]
8. Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for childhood acute lymphoblastic leukemia.
Chen Z; Yang F; Liu H; Fan F; Lin Y; Zhou J; Cai Y; Zhang X; Wu Y; Mao R; Zhang T
Aging (Albany NY); 2021 Jun; 13(11):15548-15568. PubMed ID: 34106877
[TBL] [Abstract][Full Text] [Related]
9. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238.
Liang C; Li Y; Wang LN; Zhang XL; Luo JS; Peng CJ; Tang WY; Huang LB; Tang YL; Luo XQ
Hematology; 2021 Dec; 26(1):16-25. PubMed ID: 33357126
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
Rashed WM; Hammad AM; Saad AM; Shohdy KS
Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the miRNA profiling and effectiveness of the propolis on B-cell acute lymphoblastic leukemia cell line.
Yilmaz UC; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Gunduz C; Cogulu O
Biomed Pharmacother; 2016 Dec; 84():1266-1273. PubMed ID: 27810783
[TBL] [Abstract][Full Text] [Related]
14. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16.
Qian D; Chen K; Deng H; Rao H; Huang H; Liao Y; Sun X; Lu S; Yuan Z; Xie D; Cai Q
Clin Cancer Res; 2015 Nov; 21(21):4881-91. PubMed ID: 26100275
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review.
Rashed WM; Hamza MM; Matboli M; Salem SI
Cancer Metastasis Rev; 2019 Dec; 38(4):771-782. PubMed ID: 31807971
[TBL] [Abstract][Full Text] [Related]
18. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
Han BW; Feng DD; Li ZG; Luo XQ; Zhang H; Li XJ; Zhang XJ; Zheng LL; Zeng CW; Lin KY; Zhang P; Xu L; Chen YQ
Hum Mol Genet; 2011 Dec; 20(24):4903-15. PubMed ID: 21926415
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
Pouyanrad S; Rahgozar S; Ghodousi ES
Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.
Longjohn MN; Squires WRB; Christian SL
Gene; 2022 May; 821():146211. PubMed ID: 35134470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]